Blueshift Asset Management, LLC Regenxbio Inc. Transaction History

Blueshift Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$19.35 - $35.04 $234,212 - $424,124	-12,104 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$24.62 - $34.31 $298,000 - $415,288	12,104 New	12,104 $402,000
Q3 2021 Nov 12, 2021	SELL	$29.09 - $45.68 $329,938 - $518,102	-11,342 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$32.46 - $40.48 $368,161 - $459,124	11,342 New	11,342 $441,000
Q1 2019 May 14, 2019	SELL	$40.82 - $62.45 $311,946 - $477,242	-7,642 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$39.11 - $75.15 $298,878 - $574,296	7,642 New	7,642 $321,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.